Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Imperial College London Magstim Company, Whitland, Wales |
---|---|
Information provided by: | Imperial College London |
ClinicalTrials.gov Identifier: | NCT00159367 |
We intend to use repetitive magnetic stimulation to the quadriceps muscle to try to improve strength and improve the metabolic function of the muscle.
Condition | Intervention |
---|---|
Chronic Obstructive Pulmonary Disease |
Device: Repetitive magnetic stimulation to the quadriceps |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps Muscle in Patients With Chronic Obstructive Pulmonary Disease |
Estimated Enrollment: | 20 |
Study Start Date: | January 2005 |
Study Completion Date: | February 2006 |
Primary Completion Date: | February 2006 (Final data collection date for primary outcome measure) |
Quadriceps strength is reduced in COPD. Increasing quadriceps strength is one of the goals of pulmonary rehabilitation yet some patients with severe COPD are unable to exercise with sufficient intensity, due to breathlessness, to achieve a true training benefit.
Transcutaneous electrical stimulation of the femoral nerve has been shown to improve quadriceps muscle strength, muscle mass, and performance in patients with severe COPD. Magnetic stimulation may be preferred because it offers the opportunity to train the whole muscle and because it is painless. In this pilot study we are investigating whether repetitive magnetic stimulation camn increase the strength of the quadriceps muscle and whether it confers any change in structure or metabolism of the muscle itself.
Ages Eligible for Study: | 40 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Chronic Obstructive Pulmonary Disease
Exclusion Criteria:
Aspirin therapy Cardiac Pacemaker
-
United Kingdom | |
Royal Brompton Hospital | |
London, United Kingdom, Sw3 6NP |
Principal Investigator: | Michael I Polkey, PhD | Imperial College London |
Responsible Party: | Royal brompton Hospital/Imperial College ( Professor Michael I Polkey ) |
Study ID Numbers: | RR1, EU QLRT-2001-2285 |
Study First Received: | September 9, 2005 |
Last Updated: | August 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00159367 |
Health Authority: | United Kingdom: Research Ethics Committee |
Neuromuscular electrical stimulation |
Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive |